Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Anna Llort"'
Autor:
Laura Escudero, Anna Llort, Alexandra Arias, Ander Diaz-Navarro, Francisco Martínez-Ricarte, Carlota Rubio-Perez, Regina Mayor, Ginevra Caratù, Elena Martínez-Sáez, Élida Vázquez-Méndez, Iván Lesende-Rodríguez, Raquel Hladun, Luis Gros, Santiago Ramón y Cajal, Maria A. Poca, Xose S. Puente, Juan Sahuquillo, Soledad Gallego, Joan Seoane
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Non-invasive and precise methods are critical for monitoring paediatric brain cancers. Here the authors show that the molecular alterations and heterogeneity of paediatric medulloblastomas can be reliably detected in circulating tumour DNA from the c
Externí odkaz:
https://doaj.org/article/c3bf556831fd4765979786b61390d38a
Autor:
Luz Jubierre, Carlos Jiménez, Eric Rovira, Aroa Soriano, Constantino Sábado, Luis Gros, Anna Llort, Raquel Hladun, Josep Roma, Josep Sánchez de Toledo, Soledad Gallego, Miguel F. Segura
Publikováno v:
Experimental and Molecular Medicine, Vol 50, Iss 4, Pp 1-12 (2018)
Cancer therapy: Exploring an epigenetic approach Treatments that target chromatin, the combination of DNA and proteins, are emerging as alternative ways to treat aggressive neuroblastomas, cancers of neural tissue. Altering the structure and function
Externí odkaz:
https://doaj.org/article/44a3f605201c49468d79e2635c1fc5f8
Autor:
Vicente Notario, Heinrich Kovar, Jozef Ban, Soledad Gallego, Anna Llort, Luis E. Dettin, Joaquín Villar, Silvia Mateo-Lozano, Oscar M. Tirado
Supplementary Table 1 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620ccc649675176192a7587e27de5b01
https://doi.org/10.1158/0008-5472.22364712
https://doi.org/10.1158/0008-5472.22364712
Autor:
Vicente Notario, Heinrich Kovar, Jozef Ban, Soledad Gallego, Anna Llort, Luis E. Dettin, Joaquín Villar, Silvia Mateo-Lozano, Oscar M. Tirado
Tumors of the Ewing's sarcoma family (ESFT), such as Ewing's sarcoma (EWS) and primitive neuroectodermal tumors (PNET), are highly aggressive malignancies predominantly affecting children and young adults. ESFT express chimeric transcription factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709f8995f76a1361ad3964d8d57b7284
https://doi.org/10.1158/0008-5472.c.6494322
https://doi.org/10.1158/0008-5472.c.6494322
Autor:
Vicente Notario, Heinrich Kovar, Jozef Ban, Soledad Gallego, Anna Llort, Luis E. Dettin, Joaquín Villar, Silvia Mateo-Lozano, Oscar M. Tirado
Supplementary Figures 1-4 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03227aab30b8dbde9587a719c4d6ab78
https://doi.org/10.1158/0008-5472.22364718.v1
https://doi.org/10.1158/0008-5472.22364718.v1
Autor:
Vicente Notario, Heinrich Kovar, Jozef Ban, Soledad Gallego, Anna Llort, Luis E. Dettin, Joaquín Villar, Silvia Mateo-Lozano, Oscar M. Tirado
Supplementary Table 2 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e4aecf4a715ebc0e2e249896caca78c
https://doi.org/10.1158/0008-5472.22364709.v1
https://doi.org/10.1158/0008-5472.22364709.v1
Autor:
Vicente Notario, Heinrich Kovar, Jozef Ban, Soledad Gallego, Anna Llort, Luis E. Dettin, Joaquín Villar, Silvia Mateo-Lozano, Oscar M. Tirado
Supplementary Methods, Figure and Table Legends from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3627ebdccfd12dd25f366d34b88b1728
https://doi.org/10.1158/0008-5472.22364715.v1
https://doi.org/10.1158/0008-5472.22364715.v1
Autor:
Audrey-Anne Lamoureux, Michael Fisher, Lauriane Lemelle, Elke Pfaff, Christof Kramm, Bram De Wilde, Bernarda Kazanowska, Caroline Hutter, Stefan M Pfister, Dominik Sturm, David Jones, Daniel Orbach, Gaëlle Pierron, Scott Raskin, Alexander Drilon, Eli Diamond, Guilherme Harada, Michal Zapotocky, Benjamin Ellezam, Alexander G Weil, Dominic Venne, Marc Barritault, Pierre Leblond, Hallie Coltin, Rawan Hammad, Uri Tabori, Cynthia Hawkins, Jordan R Hansford, Deborah Meyran, Craig Erker, Kathryn McFadden, Mariko Sato, Nicholas G Gottardo, Hetal Dholaria, Dorte Schou Nørøxe, Hiroaki Goto, David S Ziegler, Frank Y Lin, Donald Williams Parsons, Holly Lindsay, Tai-Tong Wong, Yen-Lin Liu, Kuo-Sheng Wu, Andrea Flynn Franson, Eugene Hwang, Ana Aguilar-Bonilla, Sylvia Cheng, Chantel Cacciotti, Maura Massimino, Elisabetta Schiavello, Paul Wood, Lindsey M Hoffman, Andréa Cappellano, Alvaro Lassaletta, An Van Damme, Anna Llort, Nicolas U Gerber, Mariella Spalato Ceruso, Anne E Bendel, Maggie Skrypek, Dima Hamideh, Naureen Mushtaq, Andrew Walter, Nada Jabado, Aysha Alsahlawi, Jean-Pierre Farmer, Christina Coleman Abadi, Sabine Mueller, Claire Mazewski, Dolly Aguilera, Nathan Robison, Katrina O’Halloran, Samuel Abbou, Pablo Berlanga, Birgit Geoerger, Ingrid Øra, Christopher L Moertel, Evangelia D Razis, Anastasia Vernadou, François Doz, Theodore W Laetsch, Sébastien Perreault
Publikováno v:
Neuro-Oncology. 24:i61-i62
BACKGROUND: TRK fusions are detected in less than 3% of CNS tumors. Given their rarity, there are limited data on the clinical course of these patients. METHODS: We contacted 166 oncology centers worldwide to retrieve data on patients with TRK fusion
Autor:
Roberta Antonelli, Carlos Jiménez, Tiziana Servidei, Riccardo Riccardi, Elena Martínez-Saez, Josep Sánchez de Toledo, Josep Roma, Soledad Gallego, Anna Llort, Lucas Moreno, Miguel Segura
Publikováno v:
Neuro-Oncology. 24:i39-i39
Pediatric brain tumors (PBTs) represent the most common solid malignancies in children and the leading cause of cancer-related deaths. Despite the fact that survival after a high-grade brain tumor diagnosis is slowly improving, overall survival remai
Autor:
Francisco Bautista, Soledad Gallego, Adela Cañete, Jaume Mora, Cristina Díaz de Heredia, Ofelia Cruz, José María Fernández, Susana Rives, Pablo Berlanga, Raquel Hladun, Antonio Juan Ribelles, Luis Madero, Manuel Ramírez, Rafael Fernández Delgado, Antonio Pérez-Martínez, Cristina Mata, Anna Llort, Javier Martín Broto, María Elena Cela, Gema Ramírez, Constantino Sábado, Tomás Acha, Itziar Astigarraga, Ana Sastre, Ascensión Muñoz, Mercedes Guibelalde, Lucas Moreno
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Anales de Pediatría (English Edition), Vol 87, Iss 3, Pp 155-163 (2017)
instname
Anales de Pediatría (English Edition), Vol 87, Iss 3, Pp 155-163 (2017)
[Introduction] Cancer is the leading cause of death between the first year of life and adolescence, and some types of diseases are still a major challenge in terms of cure. There is, therefore, a major need for new drugs. Recent findings in cancer bi